Quantitative estimates of vascularity in a collagen-based cell scaffold containing basic fibroblast growth factor by non-invasive near-infrared spectroscopy for regenerative medicine

被引:0
作者
Kushibiki, Toshihiro [1 ]
Awazu, Kunio [2 ]
机构
[1] Osaka Univ, Frontier Res Ctr, Grad Sch Engn, Frontier Res Ctr Global Young Res, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, Suita, Osaka 5650871, Japan
来源
BIOPHOTONICS: PHOTONIC SOLUTIONS FOR BETTER HEALTH CARE | 2008年 / 6991卷
关键词
near infrared spectroscopy (NIRS); regenerative medicine; hemoglobin; basic fibroblast growth factor (bFGF); cell scaffolds; collagen;
D O I
10.1117/12.780771
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Successful tissue regeneration required both cells with high proliferative and differentiation potential and an environment permissive for regeneration. These conditions can be achieved by providing cell scaffolds and growth factors that induce angiogenesis and cell proliferation. Angiogenenis within cell scaffolds is typically determined by histological examination with immunohistochemical markers for endothelium. Unfortunately, this approach requires removal of tissue and the scaffold In this study, we examined the hemoglobin content of implanted collagen-based cell scaffolds containing basic fibroblast growth factor (bFGF) in vivo by non-invasive near infrared spectroscopy (NIRS). We also compared the hemoglobin levels measured by MRS to the hemoglobin content measured with a conventional biological assay. Non-invasive NIRS recordings were performed with a custom-built near-infrared spectrometer using light guide-coupled reflectance measurements. MRS recordings revealed that absorbance increased after implantation of collagen scaffolds containing bFGF. This result correlated (R-2=0.93) with our subsequent conventional hemoglobin assay. The MRS technique provides a non-invasive method for measuring the degree of vascularization in cell scaffolds. This technique may be advantageous for monitoring angiogenesis within different cell scaffolds, a prerequisite for effective tissue regeneration.
引用
收藏
页数:5
相关论文
共 17 条
  • [1] Growth factor delivery for tissue engineering
    Babensee, JE
    McIntire, LV
    Mikos, AG
    [J]. PHARMACEUTICAL RESEARCH, 2000, 17 (05) : 497 - 504
  • [2] TIME-RESOLVED SPECTROSCOPY OF HEMOGLOBIN AND MYOGLOBIN IN RESTING AND ISCHEMIC MUSCLE
    CHANCE, B
    NIOKA, S
    KENT, J
    MCCULLY, K
    FOUNTAIN, M
    GREENFELD, R
    HOLTOM, G
    [J]. ANALYTICAL BIOCHEMISTRY, 1988, 174 (02) : 698 - 707
  • [3] Hansen S, 1998, LAB INVEST, V78, P1563
  • [4] Vascular endothelial growth factor in porcine-derived extracellular matrix
    Hodde, JP
    Record, RD
    Liang, HA
    Badylak, SF
    [J]. ENDOTHELIUM-NEW YORK, 2001, 8 (01): : 11 - 24
  • [5] HU DE, 1995, LAB INVEST, V72, P601
  • [6] Bladder regeneration by bladder acellular matrix combined with sustained release of exogenous growth factor
    Kanematsu, A
    Yamamoto, S
    Noguchi, T
    Ozeki, M
    Tabata, Y
    Ogawa, O
    [J]. JOURNAL OF UROLOGY, 2003, 170 (04) : 1633 - 1638
  • [7] Collagenous matrices as release carriers of exogenous growth factors
    Kanematsu, A
    Yamamoto, S
    Ozeki, M
    Noguchi, T
    Kanatani, I
    Ogawa, O
    Tabata, Y
    [J]. BIOMATERIALS, 2004, 25 (18) : 4513 - 4520
  • [8] Quantitative estimates of angiogenic and anti-angiogenic activity by laser Doppler flowmetry (LDF) and near infra-red spectroscopy (NIRS)
    Kragh, M
    Quistorff, B
    Kristjansen, PEG
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (07) : 924 - 929
  • [9] Simultaneous application of basic fibroblast growth factor and hcpatocyte growth factor to enhance the blood vessels formation
    Marui, A
    Kanematsu, A
    Yamahara, K
    Doi, K
    Kushibiki, T
    Yamamoto, M
    Itoh, H
    Ikeda, T
    Tabata, Y
    Komeda, M
    [J]. JOURNAL OF VASCULAR SURGERY, 2005, 41 (01) : 82 - 90
  • [10] Controlled release of hepatocyte growth factor from gelatin hydrogels based on hydrogel degradation
    Ozeki, M
    Ishii, T
    Hirano, Y
    Tabata, Y
    [J]. JOURNAL OF DRUG TARGETING, 2001, 9 (06) : 461 - 471